Clinical Trial Update: Molecular Breast Imaging (MBI) in Patients With Suspected Ductal Carcinoma in Situ (DCIS)

View source ↗

Summary

This ClinicalTrials.gov update notes the completion of a study evaluating Molecular Breast Imaging (MBI) in patients with suspected ductal carcinoma in situ (DC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Snippet

Sponsor: Mayo Clinic | Conditions: Breast Cancer | Status: COMPLETED